Poly Medicure Ltd Q3 FY26 Earnings Analysis

Published 4 Aug 2026 | Healthcare Equipment & Supplies | Market Cap: ₹15.3K Cr

Price

1,728

Market Cap

₹15.3K Cr

P/E Ratio

43.5

Earnings Summary

No information is provided regarding the same in the latest conference call. No information is provided regarding the same in the latest conference call.

📊 Revenue & Sales Performance

No information is provided regarding the same in the latest conference call.

📈 Profitability & Margins

No information is provided regarding the same in the latest conference call.

🏗️ Capital Expenditure Plans

No information is provided regarding the same in the latest conference call.

💰 Fundraising & Capital Structure

No information is provided regarding the same in the latest conference call.

📋 Order Book & Pipeline

No information is provided regarding the same in the latest conference call.

Key Metrics

Frequently Asked Questions

What were Poly Medicure Ltd Q3 FY26 results?

No information is provided regarding the same in the latest conference call. No information is provided regarding the same in the latest conference call.

What is Poly Medicure Ltd share price analysis?

Poly Medicure Ltd currently shows a neutral. The stock trades at a P/E of 43.5 with a market cap of ₹15,327. Investors should review the full earnings analysis for detailed insights.

Is Poly Medicure Ltd planning capital expenditure?

No information is provided regarding the same in the latest conference call.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Healthcare Equipment & Supplies this season

  • Prevest Denpro Ltd (Q3 FY26)

    Prevest Denpro Ltd Q3 FY26 quarterly results analysis. - Prevest DenPro expects to cross Rs. Market Cap ₹485, P/E 23.6. AI-powered earnings insights.

  • OSEL Devices Ltd (Q3 FY26)

    OSEL Devices Ltd Q3 FY26 quarterly results analysis. - Expecting good growth driven primarily by Philips mobile phone sales, especially with smartphones adding

  • Vasa Denticity Ltd (Q3 FY26)

    Vasa Denticity Ltd Q3 FY26 quarterly results analysis. - Targeting ₹500–600 crore revenue by FY27, broadly on track with directional targets. Market Cap ₹757, P

  • Fischer Medical Ventures Ltd (Q3 FY26)

    Fischer Medical Ventures Ltd Q3 FY26 quarterly results analysis. - Fischer Medical Ventures targets a 15%-20% market share in the domestic and Asian MRI markets